Open | $7.100 |
Close | $6.085 |
Volume / Avg. | 1.093M / 772.159K |
Day Range | 6.070 - 7.150 |
52 Wk Range | 3.260 - 14.044 |
Market Cap | $398.254M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | % |
Days to Cover | 7.52 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Terns Pharma (NASDAQ: TERN) through any online brokerage.
Other companies in Terns Pharma’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA) and GH Research (NASDAQ:GHRS).
The latest price target for Terns Pharma (NASDAQ: TERN) was reported by JMP Securities on Monday, March 18, 2024. The analyst firm set a price target for 15.00 expecting TERN to rise to within 12 months (a possible 143.51% upside). 24 analyst firms have reported ratings in the last year.
The stock price for Terns Pharma (NASDAQ: TERN) is $6.16 last updated March 18, 2024 at 7:57 PM EDT.
There are no upcoming dividends for Terns Pharma.
Terns Pharma’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Terns Pharma.
Terns Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.